Literature DB >> 16553158

PET/CT following intensity-modulated radiation therapy for primary lung tumor in a dog.

Elizabeth A Ballegeer1, Lisa J Forrest, Robert Jeraj, T Rockwell Mackie, R Jerome Nickles.   

Abstract

A primary lung tumor in a dog treated with intensity-modulated radiation therapy was imaged approximately 6 weeks and 1-year posttreatment with combined positron emission tomography (PET) and computed tomography, utilizing the radiotracers 18F-fluorodeoxyglucose and 18F-fluorothymidine. These two tracers allowed discrimination of tumor from inflammation, and demonstrated spread of tumor along airways over time after treatment. Fusion of functional imaging with anatomic imaging is a useful tool, particularly in the field of oncology, with the potential for PET markers that delineate tumor from normal or reactive tissue, and potential or actual response to therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16553158     DOI: 10.1111/j.1740-8261.2006.00132.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  6 in total

1.  Positron emission tomography/computed tomography imaging features of renal cell carcinoma and pulmonary metastases in a dog.

Authors:  Sun-Hye Song; Noh-Won Park; Ki-Dong Eom
Journal:  Can Vet J       Date:  2014-05       Impact factor: 1.008

2.  Clinical outcome in dogs with nasal tumors treated with intensity-modulated radiation therapy.

Authors:  David W Hunley; G Neal Mauldin; Keijiro Shiomitsu; Glenna E Mauldin
Journal:  Can Vet J       Date:  2010-03       Impact factor: 1.008

3.  Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors.

Authors:  Stefanie M F Seiler; Christine Baumgartner; Johannes Hirschberger; Ambros J Beer; Andreas Brühschwein; Nina Kreutzmann; Silja Laberke; Melanie C Wergin; Andrea Meyer-Lindenberg; Johanna Brandl; Anne-Kathrin von Thaden; Eliane Farrell; Markus Schwaiger
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

4.  Use of Molecular Imaging Markers of Glycolysis, Hypoxia and Proliferation ((18)F-FDG, (64)Cu-ATSM and (18)F-FLT) in a Dog with Fibrosarcoma: The Importance of Individualized Treatment Planning and Monitoring.

Authors:  Kamilla Westarp Zornhagen; Malene M Clausen; Anders E Hansen; Ian Law; Fintan J McEvoy; Svend A Engelholm; Andreas Kjær; Annemarie T Kristensen
Journal:  Diagnostics (Basel)       Date:  2015-09-11

Review 5.  The Importance of the Tumor Microenvironment and Hypoxia in Delivering a Precision Medicine Approach to Veterinary Oncology.

Authors:  Mark Gray; James Meehan; Arran K Turnbull; Carlos Martínez-Pérez; Charlene Kay; Lisa Y Pang; David J Argyle
Journal:  Front Vet Sci       Date:  2020-11-12

6.  Relative skeletal distribution of proliferating marrow in the adult dog determined using 3'-deoxy-3'-[18 F]fluorothymidine.

Authors:  Joshua A Rowe; Federica Morandi; Dustin R Osborne; Jonathan S Wall; Stephen J Kennel; Robert B Reed; Amy K LeBlanc
Journal:  Anat Histol Embryol       Date:  2018-10-23       Impact factor: 1.114

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.